- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.18 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 10 residues within 4Å:- Chain A: K.35, G.36, F.37, C.38, M.39, M.351, S.458, G.460, G.461, L.463
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.35, A:F.37, A:C.38, A:M.39
GOL.6: 10 residues within 4Å:- Chain B: K.35, G.36, F.37, C.38, M.39, M.351, S.458, G.460, G.461, L.463
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:K.35, B:F.37, B:C.38, B:M.39
GOL.10: 10 residues within 4Å:- Chain C: K.35, G.36, F.37, C.38, M.39, M.351, S.458, G.460, G.461, L.463
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:K.35, C:F.37, C:C.38, C:M.39
GOL.14: 10 residues within 4Å:- Chain D: K.35, G.36, F.37, C.38, M.39, M.351, S.458, G.460, G.461, L.463
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:K.35, D:F.37, D:C.38, D:M.39
- 4 x MYT: METYRAPONE(Non-covalent)
MYT.3: 9 residues within 4Å:- Chain A: R.85, S.99, R.192, F.284, A.285, T.289, A.350, R.352
- Ligands: HEM.1
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.284, A:A.285, A:T.289, A:A.350
MYT.7: 9 residues within 4Å:- Chain B: R.85, S.99, R.192, F.284, A.285, T.289, A.350, R.352
- Ligands: HEM.5
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:F.284, B:A.285, B:T.289, B:A.350
MYT.11: 9 residues within 4Å:- Chain C: R.85, S.99, R.192, F.284, A.285, T.289, A.350, R.352
- Ligands: HEM.9
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:F.284, C:A.285, C:T.289, C:A.350
MYT.15: 9 residues within 4Å:- Chain D: R.85, S.99, R.192, F.284, A.285, T.289, A.350, R.352
- Ligands: HEM.13
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:F.284, D:A.285, D:T.289, D:A.350
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 3 residues within 4Å:- Chain A: N.227, R.230, K.231
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.227
- Water bridges: A:R.230
EDO.8: 3 residues within 4Å:- Chain B: N.227, R.230, K.231
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.227
- Water bridges: B:R.230
EDO.12: 3 residues within 4Å:- Chain C: N.227, R.230, K.231
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.227
- Water bridges: C:R.230
EDO.16: 3 residues within 4Å:- Chain D: N.227, R.230, K.231
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.227
- Water bridges: D:R.230
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sevrioukova, I., Interaction of Human Drug-Metabolizing CYP3A4 with Small Inhibitory Molecules. Biochemistry (2019)
- Release Date
- 2019-01-16
- Peptides
- Cytochrome P450 3A4: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
SMTL ID : 6ma6.2 (1 other biounit)
Human CYP3A4 bound to an inhibitor metyrapone
Cytochrome P450 3A4
Toggle Identical (ABCD)Related Entries With Identical Sequence
3tjs.1 | 3ua1.1 | 4d78.1 | 4d7d.1 | 4i3q.1 | 4i3q.2 | 4i4g.1 | 4i4g.2 | 4i4h.1 | 4i4h.2 | 4k9t.1 | 4k9u.1 | 4k9v.1 | 4k9w.1 | 4k9w.2 | 4k9w.3 | 4k9w.4 | 4k9x.1 | 5a1p.1 | 5a1r.1 | 5g5j.1 | 5te8.1 | 5vc0.1 | 5vc0.2 | 5vcc.1 | 5vcc.2 | 6bcz.1 | 6bd5.1 | 6bd6.1 | 6bd7.1 more...less...6bd8.1 | 6bdh.1 | 6bdi.1 | 6bdk.1 | 6bdm.1 | 6da2.1 | 6da3.1 | 6da5.1 | 6da8.1 | 6daa.1 | 6dab.1 | 6dac.1 | 6dag.1 | 6daj.1 | 6dal.1 | 6ma6.1 | 6ma8.1 | 6oo9.1 | 6ooa.1 | 6oob.1 | 6une.1 | 6une.2 | 6ung.1 | 6ung.2 | 6unh.1 | 6unh.2 | 6uni.1 | 6uni.2 | 6unj.1 | 6unj.2 | 6unj.3 | 6unk.1 | 6unk.2 | 6unl.1 | 6unl.2 | 6unm.1 | 6unm.2 | 6unm.3 | 7ks8.1 | 7ksa.1 | 7kvh.1 | 7kvi.1 | 7kvj.1 | 7kvm.1 | 7kvn.1 | 7kvo.1 | 7kvp.1 | 7kvq.1 | 7uay.1 | 7uaz.1 | 7uf9.1 | 7ufa.1 | 7ufb.1 | 7ufc.1 | 7ufd.1 | 8dyc.1 | 8ewd.1 | 8ewe.1 | 8ewl.1 | 8ewm.1 | 8ewn.1 | 8ewp.1 | 8ewq.1 | 8ewr.1 | 8ews.1 | 8exb.1 | 8so1.1 | 8so2.1 | 9bbb.1